Literature DB >> 28281003

Bone morphogenetic protein in adult spinal deformity surgery: a meta-analysis.

Gregory W Poorman1, Cyrus M Jalai1, Anthony Boniello2, Nancy Worley1, Shearwood McClelland1, Peter G Passias3.   

Abstract

INTRODUCTION: Since its introduction BMP has been utilized in populations with higher rates of malunion, such as adult spinal deformity (ASD) patients. Contradictory conclusions exist in spinal literature regarding the safety and efficacy of the use of BMP in this setting. Previous studies, however, did not distinguish deformity cases from spondylolisthesis or stenosis. The purpose of this study is to evaluate the safety and efficacy of BMP use in spinal fusion surgery for ASD.
METHODS: 166 papers were screened after database search. 40 full texts were assessed for eligibility. Five studies were included for meta-analysis. Three were comparative studies between a BMP and non-BMP group, and the other was used to supplement dose-effect analysis.
RESULTS: The current meta-analysis found increased odds of developing radiculitis or neurological complications (OR = 2.18, 95% CI, p = 0.02, i 2 = 0), but no other significant relationship between complications commonly attributed to BMP use (tumorigenesis, infections, seroma formation, or osteolysis) and BMP use. BMP patients had decreased rates of pseudarthrosis (OR = 0.23, 95% CI, p = 0.002, i 2 = 0). There was an average dose of 8.75 mg/level in the 417 patients studied, lower than the advised dosage of 12 mg/level.
CONCLUSIONS: The current literature shows BMP to be a safe and effective grafting technique in the treatment of ASD. Spine surgeons may currently be using sub-optimal doses of BMP. The benefit of increasing the rate of fusion must be weighed against the increased risk of radiculitis and neurologic complications in this patient population.

Entities:  

Keywords:  Adult spinal deformity; Bone morphogenetic protein; Spine surgery; Thoracolumbar fusion

Mesh:

Substances:

Year:  2017        PMID: 28281003     DOI: 10.1007/s00586-016-4841-5

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  36 in total

1.  End plates resorptions after the applications of rhBMP-2 for interbody spinal fusions.

Authors:  Tomislav Smoljanovic; Ivan Bojanic; Marko Pecina
Journal:  J Spinal Disord Tech       Date:  2009-06

2.  The use of bone morphogenetic protein in lumbar spine surgery.

Authors:  Tomislav Smoljanović; Ivan Bojanić; Marko Pećina
Journal:  J Bone Joint Surg Am       Date:  2009-08       Impact factor: 5.284

3.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  Int J Surg       Date:  2010-02-18       Impact factor: 6.071

Review 4.  Complications following autologous bone graft harvesting from the iliac crest and using the RIA: a systematic review.

Authors:  Rozalia Dimitriou; George I Mataliotakis; Antonios G Angoules; Nikolaos K Kanakaris; Peter V Giannoudis
Journal:  Injury       Date:  2011-06-25       Impact factor: 2.586

Review 5.  Safety profile for the clinical use of bone morphogenetic proteins in the spine.

Authors:  Ashley R Poynton; Joseph M Lane
Journal:  Spine (Phila Pa 1976)       Date:  2002-08-15       Impact factor: 3.468

6.  RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age.

Authors:  Steven D Glassman; Leah Y Carreon; Mladen Djurasovic; Mitchell J Campbell; Rolando M Puno; John R Johnson; John R Dimar
Journal:  Spine (Phila Pa 1976)       Date:  2008-12-15       Impact factor: 3.468

7.  Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2).

Authors:  David A Wong; Anant Kumar; Sanjay Jatana; Gary Ghiselli; Katherine Wong
Journal:  Spine J       Date:  2007-11-26       Impact factor: 4.166

Review 8.  Perioperative and long-term clinical outcomes for bone morphogenetic protein versus iliac crest bone graft for lumbar fusion in degenerative disk disease: systematic review with meta-analysis.

Authors:  Andriy Noshchenko; Lilian Hoffecker; Emily M Lindley; Evalina L Burger; Christopher M J Cain; Vikas V Patel
Journal:  J Spinal Disord Tech       Date:  2014-05

9.  The use of rhBMP in spine surgery: is there a cancer risk?

Authors:  John G Devine; Joseph R Dettori; John C France; Erika Brodt; Robert A McGuire
Journal:  Evid Based Spine Care J       Date:  2012-05

10.  A meta analysis of lumbar spinal fusion surgery using bone morphogenetic proteins and autologous iliac crest bone graft.

Authors:  Haifei Zhang; Feng Wang; Lin Ding; Zhiyu Zhang; Deri Sun; Xinmin Feng; Jiuli An; Yue Zhu
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

View more
  5 in total

Review 1.  Therapeutics for enhancement of spinal fusion: A mini review.

Authors:  Yidan Zhang; Yu Jiang; Da Zou; Baozhi Yuan; Hua Zhu Ke; Weishi Li
Journal:  J Orthop Translat       Date:  2021-12-06       Impact factor: 5.191

2.  Differences in primary and revision deformity surgeries: following 1,063 primary thoracolumbar adult spinal deformity fusions over time.

Authors:  Gregory W Poorman; Peter L Zhou; Dennis Vasquez-Montes; Samantha Horn; Cole Bortz; Frank Segreto; Joshua Auerbach; John Y Moon; Jared C Tishelman; Michael C Gerling; Bassel G Diebo; Rafael De La Garza-Ramos; Justin C Paul; Peter G Passias
Journal:  J Spine Surg       Date:  2018-06

Review 3.  Advances in Spinal Fusion Strategies in Adult Deformity Surgery.

Authors:  Jeremy Steinberger; Philip York; Sohrab Virk; Han Jo Kim
Journal:  HSS J       Date:  2020-02-04

Review 4.  Minimally Invasive Spinal Surgery for Adult Spinal Deformity.

Authors:  Junseok Bae; Sang-Ho Lee
Journal:  Neurospine       Date:  2018-03-28

5.  Recombinant Human Bone Morphogenetic Protein-2 Use in Adult Spinal Deformity Surgery: Comparative Analysis and Healthcare Utilization at 24 Months' Follow-up.

Authors:  Nicholas Dietz; Mayur Sharma; Michael Kelly; Beatrice Ugiliweneza; Dengzhi Wang; Joseph Osorio; Isaac Karikari; Doniel Drazin; Maxwell Boakye
Journal:  Global Spine J       Date:  2020-08-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.